Darrin M. Beaupre is currently working in the position of Chief Medical Officer, Oncology, at Biosplice Therapeutics. Beaupre is a Medical Oncologist and Hematologist with 14 years of industry experience in both early and late phase clinical development.

Prior to joining Biosplice, Beaupre was the head of Early Oncology Development and Clinical Research at Pfizer and the Head of Early Development as well as the Immunotherapy and Non-Hodgkin’s Lymphoma Therapeutic Area head at Pharmacyclics. He previously served as an Assistant Professor at the Moffit Cancer Center in the Department of Interdisciplinary Oncology. He received a Clinical Scholars in Oncology Award from the National Cancer Institute and was nominated as “new scientist to watch” by the Leukemia Research Foundation.

Beaupre completed his Medical Oncology and Hematology Fellowship and post-doctoral research training at the University of Miami Sylvester Cancer Center. He completed his MD and PhD in Cancer Biology at the University of Texas at Houston and MD Anderson Cancer Center, respectively. He also received an MS degree in Biotechnology and BS degree in Biology at the University of Lowell in Lowell, Massachusetts.